Feng Ren
Vermögen: 3 Mio $ am 31.05.2026
Vermögen: 3 Mio $ am 31.05.2026
Feng Ren is currently Co-Chief Executive Officer & Executive Director at InSilico Medicine Cayman TopCo since 2023 and Co-CEO, Director & Chief Scientific Officer at InSilico Medicine, Inc. Formerly, Dr. Ren was Director & Head-Chemistry at GSK Plc from 2007 to 2018 and Senior Vice President & Head-Chemistry & Biology at Shanghai Medicilon, Inc. from 2018 to 2021.
Education includes a doctorate from Harvard University in 2007, a graduate degree from National University of Singapore in 2004, and an undergraduate degree from the University of Science & Technology of China in 1998.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.12.2025 | 475.400 ( 0,08 % ) | 3 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| INSILICO MEDICINE CAYMAN TOPCO | Vorstandsvorsitzender | 01.06.2022 |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence multiple global collaborations platform | Vorstandsvorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
| SHANGHAI MEDICILON INC. | Corporate Officer/Principal | 01.01.2021 |
| GSK PLC | Direktor/Vorstandsmitglied | 01.01.2018 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National University of Singapore
National University of Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Science & Technology of China
University of Science & Technology of China Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Medicilon, Inc.
Shanghai Medicilon, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and develop biotechnology drug discovery contract research organization | Commercial Services |
InSilico Medicine, Inc.
InSilico Medicine, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence multiple global collaborations platform | Technology Services |
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Pharmaceuticals: MajorHealth Technology Develops therapeutic pipeline technology and AI software platform | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen